MTOR and gastric cancer: The aforementioned findings indicated that EM in combination with DDP ameliorated the chemoresistance of DDP in gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway, thus the combination of the two drugs acts as a sensitizer and enhancer.